Stoke Therapeutics, Inc. - stock earnings
STOK Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| May 2, 2024 BeforeMarket | -0.60 / -0.60 | - | - / 3.2 million | - |
STOK Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -24.5 million USD | 3.3 million USD |
| 2023Q2 | -30.7 million USD | -2.5 million USD |
| 2023Q1 | -18.3 million USD | 5.2 million USD |
| 2022Q4 | -22.0 million USD | 3.3 million USD |
| 2022Q3 | -24.1 million USD | 2.9 million USD |
| 2022Q2 | -23.2 million USD | 3.2 million USD |
| 2022Q1 | -24.4 million USD | 3.0 million USD |
| 2021Q4 | -24.4 million USD | ? USD |
| 2021Q3 | -22.6 million USD | ? USD |
| 2021Q2 | -22.0 million USD | ? USD |
| 2021Q1 | -16.8 million USD | ? USD |
| 2020Q4 | -14.6 million USD | ? USD |
| 2020Q3 | -13.7 million USD | ? USD |
| 2020Q2 | -13.0 million USD | ? USD |
| 2020Q1 | -11.0 million USD | ? USD |
| 2019Q4 | -10.2 million USD | ? USD |
| 2019Q3 | -8.6 million USD | ? USD |
| 2019Q2 | -7.8 million USD | ? USD |
| 2019Q1 | -5.7 million USD | ? USD |
| 2018Q4 | -4.3 million USD | ? USD |
| 2018Q3 | -3.3 million USD | ? USD |
| 2018Q2 | -3.0 million USD | ? USD |
| 2018Q1 | -1.9 million USD | ? USD |
STOK Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -103.4 million USD | 9.2 million USD |
| 2022 | -93.1 million USD | 12.4 million USD |
| 2021 | -84.7 million USD | 3.0 million USD |
| 2020 | -50.6 million USD | ? USD |
| 2019 | -28.5 million USD | ? USD |
| 2018 | -12.5 million USD | ? USD |
| 2017 | -5.6 million USD | ? USD |
STOK
Price: $11.69
52 week price:
Earnings Per Share: -2.38 USD
P/E Ratio: -1.81
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 66686
Market Capitalization: 558.8 million